Immobilised biological entities
First Claim
1. A cationic hyperbranched polymer molecule characterized by having (i) a core moiety of molecular weight 14-1,000 Da (ii) a total molecular weight of 10,000 to 300,000 Da (iii) a ratio of total molecular weight to core moiety molecular weight of at least 80:
- 1 and (iv) functional end groups, whereby one or more of said functional end groups have a heparin moiety covalently attached thereto, and wherein the hyperbranched polymer is not a dendrimer.
8 Assignments
0 Petitions
Accused Products
Abstract
There is described inter alia a device having a surface comprising a layered coating wherein the outer coating layer comprises a plurality of cationic hyperbranched polymer molecules characterized by having (i) a core moiety of molecular weight 14-1,000 Da (ii) a total molecular weight of 1,500 to 1,000,000 Da (iii) a ratio of total molecular weight to core moiety molecular weight of at least 80:1 and (iv) functional end groups, whereby one or more of said functional end groups have an anti-coagulant entity covalently attached thereto.
66 Citations
12 Claims
-
1. A cationic hyperbranched polymer molecule characterized by having (i) a core moiety of molecular weight 14-1,000 Da (ii) a total molecular weight of 10,000 to 300,000 Da (iii) a ratio of total molecular weight to core moiety molecular weight of at least 80:
- 1 and (iv) functional end groups, whereby one or more of said functional end groups have a heparin moiety covalently attached thereto, and wherein the hyperbranched polymer is not a dendrimer.
- View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)
Specification